NICHOLAS BROOKINS: Open Payments
NPI 1215283098 · PUEBLO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$74 in 4 payments from 4 companies in 2025. Trend: 2023 $49 · 2024 $26 · 2025 $74
Food & beverage: $74
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: Veozah, OFEV, AREXVY, TRINTELLIX.
Industry payments across CO — which companies pay providers there.
